Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

JMP Securities Downgrades Trillium Therapeutics to Market Perform

JMP Securities analyst Reni Benjamin downgrades Trillium Therapeutics (NASDAQ:TRIL) from Market Outperform to Market Perform.
byBenzinga Newsdesk
August 24, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

JMP Securities analyst Reni Benjamin downgrades Trillium Therapeutics (NASDAQ:TRIL) from Market Outperform to Market Perform.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0